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1. Clinical Presentation
A 22-year-old girl visited the urology outpatient clinic 
with chief complaints of urinary frequency, difficulty in 
urination, and urge incontinence. Her history revealed 
that she had experienced acute onset of four-limb/trunk 
numbness with hiccup, severe swallowing difficulty, hoarse-
ness, and bilateral facial weakness 6 months previously. 
Magnetic resonance imaging revealed focal edema in the 
lower dorsal medulla oblongata and a long segment of 
edema from the lower brain stem to the upper thoracic 
spinal cord. Difficulty in urination and constipation were 
associated with the overactive bladder symptoms. She 
received endotracheal tube with ventilator support be-
cause of respiratory failure. The symptoms improved 3 
weeks later with neurologic sequelae of mild numbness 
in the distal fingers after medication and rehabilitation 
therapy. She recovered to be able to walk slowly without 
assistance and needed intermittent urinary catheterization 
twice a day with residual urine amount of 160–180 mL. 
Multiple sclerosis (MS) was diagnosed by neurologists.
2. Videourodynamic Studies and Findings
Free uroflowmetry was arranged (Figure 1) and 3-day void-
ing diary was acquired (Figure 2). Videourodynamic study 
was performed with a 7F dual-lumen vesical catheter and 
a 9F rectal balloon catheter with surface patch electromy-
ography at medium filling using radiographic contrast in 
the sitting position. Prior to the examination, the patient 
was asked to void, and post-void residual was measured 
with the catheter. The infusion rate was 20 mL/min. Dur-
ing bladder filling, the patient was instructed to neither 
void nor inhibit micturition but simply to report her sen-
sations to the examiner. If detrusor overactivities were 
detected, the patient was asked to describe what she felt 
and to try to abort the detrusor contraction voluntarily 
by contracting the sphincter.
Detrusor overactivity observed when 180 mL normal 
saline was infused into urinary bladder (Figure 3). The 
involuntary contraction could not be inhibited by the patient 
herself and urine leakage proceeded. Detrusor-sphincter 
dyssynergia was detected using electromyography.
3. Treatments and Follow-up
Under the impression of detrusor overactivity with 
detrusor-sphincter dyssynergia, 120 units of botulinum 
toxin A was injected into the submucosa of the urinary 
bladder, another 80 units of botulinum toxin A was ad-
ministered to the external sphincter. There was no urge 
or stress urinary incontinence after the therapy. The symp-
toms of overactive bladder were much improved. Although 
the patient still required straining to void, voiding was 
easier. The maximum urine flow rate improved from 12 
to 20 mL/s (Figure 4). Self-catheterization was performed 
before bedtime with residual urine amount of 100–200 mL. 
There was no episode of urinary tract infection during 
the follow-up period. Recurrent overactive bladder symp-
toms were observed about 8 months after the botulinum 
toxin injection. She received the same regime of therapy 
every 9 months.
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4. Discussion
MS is a rare disease in Taiwan. The prevalence was as low 
as 1.9 per 100,000 in Taiwan.1 However, the distribution 
of MS is uneven, with prevalence ranging between 2 and 
150 per 100,000, which is much higher than in white 
populations.2 MS affects about 85,000 people in the UK, 
and is the commonest progressive neurologic disease af-
fecting young people.3 Its diagnosis is mainly based on 
the clinical course, which is characteristically “scattered 
in time and space” within the neuraxis. Bladder dysfunc-
tion can be found in up to 75% of patients with MS.3
Considering that MS is rare in Taiwan, the experiences 
in dealing with the complications of voiding dysfunction 
in MS patients may be scarce for Taiwanese urologists. 
The main clinical presentations of voiding dysfunction are 
overactive bladder syndrome characterized by urgency, 
urinary frequency and/or urge incontinence (irritative 
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Figure 1 Free uroflowmetry before treatment.
Time Amount 
voided (mL)
Amount by 
catheterization (mL)
Amount 
voided (mL)
Amount by 
catheterization (mL)
Amount 
voided (mL)
Amount by 
catheterization (mL)
0000–0100 340
0100–0200 200
0200–0300 250
0300–0400
0400–0500
0500–0600 310
0600–0700 270
0700–0800
0800–0900
0900–1000 330 150 230 150 250 150
1000–1100
1100–1200
1200–1300
1300–1400
1400–1500
1500–1600 100
1600–1700
1700–1800 280
1800–1900 230 200
1900–2000 130
2000–2100
2100–2200 280 150
2200–2300 200 120 330 150
2300–0000
Total 1330 270 970 300 1630 300
Figure 2 Voiding diary.
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symptoms), with a prevalence of 37–99% in MS pa-
tients.4,5 Obstructive symptoms are also frequently re-
ported, affecting between 34% and 79% of patients and 
in 25% of cases resulting in chronic urinary retention.4,5 
Irritative and obstructive symptoms often coexist, and may 
jointly affect up to 59% of men and 51% of women.6
Urodynamic studies provide important information for 
diagnosis and treatment. A three-day voiding diary pro-
vides the voiding frequency and bladder functional ca-
pacity. Uroflowmetry measures flow patterns and residual 
urine. The videourodynamic study identifies the detrusor, 
sphincter function, and bladder outlet obstruction level.
Neurotoxins may improve refractive urinary inconti-
nence in adults with spinal cord injury or MS.7 MacDonald 
et al.7 evaluated the effectiveness of neurotoxin treat-
ments for urinary incontinence in individuals with spinal 
cord injury or MS. The results showed that botulinum toxin 
A was superior to placebo and resiniferatoxin in reducing 
daily urinary incontinence episodes.7
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Figure 3 Videourodynamic VUDS showing involuntary contraction and urine leakage proceeded by detrusor-sphincter dyssynergia.
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Figure 4 Free uroflowmetry after botulinum toxin injection to external sphincter.
